CN111647084B - 抗c-MET抗体及其在治疗癌症中的应用 - Google Patents
抗c-MET抗体及其在治疗癌症中的应用 Download PDFInfo
- Publication number
- CN111647084B CN111647084B CN202010538981.0A CN202010538981A CN111647084B CN 111647084 B CN111647084 B CN 111647084B CN 202010538981 A CN202010538981 A CN 202010538981A CN 111647084 B CN111647084 B CN 111647084B
- Authority
- CN
- China
- Prior art keywords
- antibody
- met
- seq
- variable region
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Abstract
Description
抗体 | Kon(1/Ms) | Kdis(1/s) | K<sub>D</sub>(nM) |
h7C2 | 4.31x10<sup>5</sup> | 6.87x10<sup>-5</sup> | 0.16 |
huAbF46-H1 | 3.37x10<sup>5</sup> | 8.16x10<sup>-4</sup> | 2.42 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010538981.0A CN111647084B (zh) | 2020-06-13 | 2020-06-13 | 抗c-MET抗体及其在治疗癌症中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010538981.0A CN111647084B (zh) | 2020-06-13 | 2020-06-13 | 抗c-MET抗体及其在治疗癌症中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111647084A CN111647084A (zh) | 2020-09-11 |
CN111647084B true CN111647084B (zh) | 2020-12-01 |
Family
ID=72345824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010538981.0A Active CN111647084B (zh) | 2020-06-13 | 2020-06-13 | 抗c-MET抗体及其在治疗癌症中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111647084B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105452297A (zh) * | 2013-04-30 | 2016-03-30 | 新加坡科技研究局 | mAb 2抗-Met抗体 |
CN107949571A (zh) * | 2015-06-12 | 2018-04-20 | 台湾基督长老教会马偕医疗财团法人马偕纪念医院 | 调控免疫反应的方法及抗体 |
CN110770254A (zh) * | 2017-05-30 | 2020-02-07 | 株式会社钟根堂 | 新的抗c-MET抗体及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2996059A1 (en) * | 2015-08-28 | 2017-03-09 | Alector Llc | Anti-siglec-7 antibodies and methods of use thereof |
-
2020
- 2020-06-13 CN CN202010538981.0A patent/CN111647084B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105452297A (zh) * | 2013-04-30 | 2016-03-30 | 新加坡科技研究局 | mAb 2抗-Met抗体 |
CN107949571A (zh) * | 2015-06-12 | 2018-04-20 | 台湾基督长老教会马偕医疗财团法人马偕纪念医院 | 调控免疫反应的方法及抗体 |
CN110770254A (zh) * | 2017-05-30 | 2020-02-07 | 株式会社钟根堂 | 新的抗c-MET抗体及其用途 |
Non-Patent Citations (2)
Title |
---|
"HGF/c-MET通路在癌症中的研究进展";苏会玲 等;《实用癌症杂志》;20130131;第28卷(第1期);第98-100页 * |
"immunoglobulin mu heavy chain, partial [Homo sapiens]";Kolar,G.R.等;《GenBank》;20160726;ACCESSION No.AAV40316 * |
Also Published As
Publication number | Publication date |
---|---|
CN111647084A (zh) | 2020-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5899310B2 (ja) | c−KIT抗体およびその使用 | |
US11261246B2 (en) | Anti-IL-22R antibodies | |
TWI797609B (zh) | 抗pd-1和pd-l1的四價雙特異性抗體 | |
TW202146457A (zh) | 一種抗pd-l1和her2的雙特異性抗體 | |
EP4043490A1 (en) | Humanized anti-vegf fab antibody fragment and use thereof | |
US20220144930A1 (en) | Humanized Anti-VEGF Monoclonal Antibody | |
WO2019114793A1 (zh) | 一种egfr抗体及其制备方法和应用 | |
CN111647084B (zh) | 抗c-MET抗体及其在治疗癌症中的应用 | |
CN113754774A (zh) | 一种抗pd-l1和egfr的四价双特异性抗体 | |
US20210332123A1 (en) | Anti-il-25 antibodies and use thereof | |
US20230257469A1 (en) | TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEIN | |
US20220127376A1 (en) | Combinations of binding moieties that bind egfr, her2 and her3 | |
RU2809746C2 (ru) | Гуманизированное моноклональное антитело против vegf | |
WO2024002145A1 (zh) | 结合il-17a和il-17f的抗体分子及其应用 | |
BR112021016094A2 (pt) | Combinações de porções de ligação que se ligam ao egfr, her2 e her3 | |
CN114805590A (zh) | 结合her2的双特异性抗体 | |
CA3230246A1 (en) | Bispecific antibody and use thereof | |
IL298287A (en) | Binding molecules for cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Xinyi Inventor after: Wang Taihua Inventor after: Liu Huan Inventor after: Dai Weili Inventor before: Liu Huan Inventor before: Dai Weili |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201112 Address after: 523000, building 4, building 10, building 401, innovation and Technology Park, Songshan hi tech Industrial Development Zone, Dongguan, Guangdong Applicant after: Guangdong cel Biotechnology Co., Ltd Address before: 701-286, floor 7, building 1, No. 5, guangyuanzha, Haidian District, Beijing 100081 Applicant before: Beijing Guangwei Biotechnology Co., Ltd |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201207 Address after: 611130 5 / F and 6 / F, building 11, No. 733, Section 2, Furong Avenue, Yongning Town, Wenjiang District, Chengdu City, Sichuan Province Patentee after: Cel Thomas Biotechnology (Chengdu) Co., Ltd Address before: 523000, building 4, building 10, building 401, innovation and Technology Park, Songshan hi tech Industrial Development Zone, Dongguan, Guangdong Patentee before: Guangdong cel Biotechnology Co., Ltd |
|
TR01 | Transfer of patent right |